Commentary Volume 3, Issue 1 pp 14—16

Treating transgenic Alzheimer mice with a β-secretase inhibitor, what have we learned?

Jordan Tang1, , Arun Ghosh2, ,

  • 1 Protein Studies Program, Oklahoma Medical Research Foundation, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA
  • 2 Departments of Chemistry and Medicinal Chemistry, Purdue University, West Lafayette, Indiana, USA

Received: January 12, 2011       Published: January 17, 2011
How to Cite

Copyright: © 2011 Tang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Download PDF